Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Frederick L. Locke, Saurabh Dahiya et al.|Journal of Clinical Oncology|2020

Cited by 782